Bladder cancer updates from the first half of 2026

Zoldonrasib plus daraxonrasib targets KRAS G12D in metastatic pancreatic cancer with promising early results

The impact of disease burden: Understanding patient priorities in aRCC

P-32 microparticle brachytherapy plus FOLFIRINOX shows promising local control in unresectable pancreatic cancer

Therapeutic mammoplasty: An advanced oncoplastic breast surgery technique

Adagrasib plus cetuximab shows activity but does not improve survival in KRAS G12C-mutated metastatic colorectal cancer

Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS

ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

Talquetamab plus daratumumab with or without pomalidomide improves PFS in r/r multiple myeloma

Defining breast cancer quality care around the globe

Global oncology innovations: B.J. Kennedy award for geriatric oncology

Global disparities in cancer care for conflict-affected populations: Africa's neglected crisis